iiinova — where your digital self keeps evolving

Reposted by Lydia O'Sullivan

Andrew Dullea @andrewdullea.bsky.social · 01/07/2026

Our latest systematic review has just been published in Radiography - While data from prostate cancer studies suggest potential quality of life and toxicity improvements, comparative evidence across different cancers remains sparse and of very low certainty. www.radiographyonline.com/article/S107...

radiographyonline.com

Magnetic resonance guided radiotherapy (MRgRT) and clinical outcomes: A systematic review

Magnetic resonance-guided radiotherapy (MRgRT) offers potential advantages over conventional computed tomography-guided radiotherapy (CTgRT), however its impact on clinical outcomes remains unclear.

111

Reposted by Lydia O'Sullivan

Leeds CTRU @leedsctru.bsky.social · 04/12/2025

⏳Don't miss out, early bird ends in 2 weeks! Join our 3-day Masterclass in the Design and Conduct of Complex Intervention Evaluations. Taking place across three days in the new year. ❗Limited spots are available so save your place now: lnkd.in/ekPieCFN

023

Reposted by Lydia O'Sullivan

The Institute of Cancer Research @icr.ac.uk · 14/08/2025

Recruitment to cancer #ClinicalTrials is often highly selective, and some people face barriers to participation. To prevent these issues from limiting our progress against the disease, we're working to bridge the gap between clinical trials and real-world practice ⬇️ www.icr.ac.uk/research-and...

022

Reposted by Lydia O'Sullivan

Marion Campbell @marionkcampbell.bsky.social · 18/08/2025

There has been a lot of debate recently about the promise of real world data - the routine (observational) data collected on patients eg treatments received, clinical outcomes etc – for estimating treatment effects. But can they deliver? 1/9 #MethodologyMonday #123

22816

Reposted by Lydia O'Sullivan

STITCHES Medicine - the Best of Medical Research @medicine.stitches.today · 07/05/2025

The updated SPIRIT 2025 statement enhances randomized trial protocols, adding clarity and transparency for better research practices. by Chan AW, Boutron I (...) Hróbjartsson A et 36 al. in JAMA #MedSky 👉 get more here 📖 read the article:

jamanetwork.com

SPIRIT 2025 Statement

This Special Communication introduces the updated Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) 2025 statement, which includes substantive and structural changes to incorporate new evidence and emerging perspectives.

043

Reposted by Lydia O'Sullivan

🐩 Poodle - Miniature @johnsonpham.bsky.social · 10/12/2024

That sounds like a perfect way to kick off the day! A cup of coffee always sets the right tone. ☕😊 #nicedogs #coffeedogs #nicedaywithdog

836316

Lydia O'Sullivan @lydiaosullivan.bsky.social · 21/01/2025

Great talk Darren, thanks again. Lots of tips for us to action! @andrewdullea.bsky.social

031

Reposted by Lydia O'Sullivan

The People's Review @thepeoplesreview.ie · 18/11/2024

Hello Bluesky 👋 #ThePeoplesReview is a citizen science project inviting the public to get involved in a systematic review about health! Check out this video for more info about what The People’s Review is all about - youtu.be/4OoIjJY0tbE

youtu.be

What is The People's Review?

YouTube video by The People's Review

01612

Reposted by Lydia O'Sullivan

Kerry Hood @kerryhood.bsky.social · 09/11/2024

How should we describe randomisation to people when recruiting them to a trial? Simple little study, but useful for us all to think about how we do this - it is not just understanding that is important, we also need to consider the acceptability of the language we use. rdcu.be/dZGg1

rdcu.be

Trial participants’ self-reported understanding of randomisation phrases in participation information leaflets can be high, but acceptability of some descriptions is low, especially those linked to ga...

075

Reposted by Lydia O'Sullivan

Darren Dahly @statsepi.bsky.social · 20/09/2024

Reflection paper on establishing efficacy based on single-arm trials submitted as pivotal evidence in a marketing authorisation. www.ema.europa.eu/en/establish...

ema.europa.eu

Establishing efficacy based on single-arm trials submitted as pivotal evidence in a marketing authorisation | European Medicines Agency (EMA)

055

Reposted by Lydia O'Sullivan

Carrie Price @carrieprice.bsky.social · 14/02/2024

Can I make another public service announcement, akin to the "don't ask your students to do systematic or scoping review but rather assign targeted activities that could help them perform one in the future?" A thread!

194